Astera Labs (NASDAQ:ALAB) Given New $275.00 Price Target at Susquehanna

Astera Labs (NASDAQ:ALAB) had its target price boosted by Susquehanna from $230.00 to $275.00 in a report published on Friday morning, Marketbeat.com reports. They currently have a neutral rating on the stock.

A number of other analysts have also recently commented on the stock. Bank of America increased their price target on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. TD Cowen boosted their price objective on shares of Astera Labs from $225.00 to $425.00 and gave the stock a “hold” rating in a research note on Monday, July 13th. Royal Bank Of Canada upped their target price on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, Roth Capital reiterated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $284.25.

Astera Labs Stock Up 3.9%

Shares of Astera Labs stock opened at $311.23 on Friday. The stock has a market cap of $53.35 billion, a P/E ratio of 210.29, a P/E/G ratio of 3.47 and a beta of 3.66. Astera Labs has a 12-month low of $97.89 and a 12-month high of $499.48. The business’s 50 day moving average is $359.97 and its 200-day moving average is $229.78.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue was up 93.5% on a year-over-year basis. During the same period last year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts expect that Astera Labs will post 1.86 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,676,845 shares of company stock worth $444,928,806 over the last ninety days. Insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Reflection Asset Management acquired a new stake in Astera Labs during the fourth quarter worth approximately $25,000. CX Institutional boosted its holdings in shares of Astera Labs by 1,330.8% during the second quarter. CX Institutional now owns 186 shares of the company’s stock worth $90,000 after acquiring an additional 173 shares during the period. Smartleaf Asset Management LLC grew its position in shares of Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in shares of Astera Labs in the fourth quarter valued at approximately $33,000. Finally, Wexford Capital LP bought a new position in shares of Astera Labs during the third quarter worth approximately $39,000. 60.47% of the stock is owned by institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.